XML 67 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Tax, Domestic and Foreign
The following table sets forth the components of the Company's (loss) income before income tax (expense) benefit:
 Years Ended December 31,
(in thousands)202420232022
United States$(31,483)$(278,741)$68,706 
Foreign(34,515)18,197 30,269 
Total (loss) income before income tax (expense) benefit $(65,998)$(260,544)$98,975 
Schedule of Components of Income Tax Expense (Benefit)
The following table sets forth the components of the Company's income tax (expense) benefit:
 Years Ended December 31,
(in thousands)202420232022
Current tax (expense):
Federal$(5,316)$(1,870)$(42,065)
State and local(1,800)(1,542)(6,579)
Foreign(6,498)(8,238)(11,096)
Total current tax (expense)(13,614)(11,650)(59,740)
Deferred tax benefit (expense):
Federal5,748 7,789 9,096 
State and local(1,677)(826)(3,439)
Foreign1,325 5,936 9,456 
Total deferred tax benefit5,396 12,899 15,113 
Total income tax (expense) benefit$(8,218)$1,249 $(44,627)
Schedule of Effective Income Tax Rate Reconciliation
The following table sets forth the principal reasons for the differences between the effective income tax rate and the statutory federal income tax rate for the Company:
 Years Ended December 31,
 202420232022
Statutory federal tax rate21.0 %21.0 %21.0 %
Foreign rate differential5.7 %0.3 %0.1 %
State and local taxes, net of federal tax benefit(10.1)%(0.8)%9.1 %
Change in value of indemnification asset— %(0.9)%(0.4)%
Non-deductible executive compensation(3.7)%(1.0)%1.8 %
Stock compensation0.2 %— %— %
Non-deductible transaction costs(1.8)%(0.2)%0.1 %
Change in federal and state valuation allowance5.2 %0.1 %(0.7)%
Change in unrecognized tax benefits (including FBOS)(3.8)%2.4 %1.9 %
Bargain purchase gain— %— %(2.2)%
Non-deductible goodwill impairment(32.8)%(21.7)%21.6 %
Federal research and development credit3.2 %0.6 %(1.4)%
Foreign exchange2.2 %(0.1)%(0.4)%
Other, net2.3 %0.8 %(5.4)%
Effective tax rate(12.4)%0.5 %45.1 %
Schedule of Deferred Tax Assets and Liabilities
The following table sets forth the significant components of the Company's deferred income tax assets and liabilities:
 Years Ended December 31,
(in thousands)20242023
Deferred tax assets
Allowance for doubtful accounts$3,887 $4,405 
Deferred and other compensation15,184 16,662 
Capital investments— 3,790 
Interest expense limitation21,677 9,680 
Fixed assets and capitalized software27,781 14,786 
Pension and other post-employment benefits10,578 18,805 
Operating lease liability2,627 3,474 
Reserve for facility exit costs4,719 4,812 
Net operating loss and credit carryforwards (1)
35,325 27,593 
Non-compete and other agreements24,375 37,615 
Goodwill and other intangible assets13,319 15,567 
Other, net13,436 8,361 
Total deferred tax assets$172,908 $165,550 
Valuation allowance(15,662)(18,810)
Net deferred tax assets$157,246 $146,740 
Deferred tax liabilities
Goodwill and other intangible assets$— $(2,587)
Deferred costs(1,754)(3,368)
Investment in subsidiaries(4,193)(4,489)
Operating lease right-of-use assets(5,323)(5,582)
Fixed assets and capitalized software(2,889)(1,099)
Other, net— (2,676)
Total deferred tax (liabilities)$(14,159)$(19,801)
Net deferred tax asset$143,087 $126,939 

(1)    For the year ended December 31, 2024, the Company had gross federal net operating loss carryforwards of $83.8 million, subject to an annual Section 382 limitation of $0.4 million. The Company also had net operating loss and credit carryforward deferred tax assets of $17.8 million and $20.9 million for the years ended December 31, 2024 and 2023, respectively, for state income tax purposes, which will begin to expire in 2025. Additionally, $1.1 million of the state net operating loss carryforward deferred tax asset is subject to a Section 382 limitation of $0.4 million.
Schedule of Deferred Tax asset Valuation Allowance
The following table sets forth changes in the Company’s valuation allowance:

(in thousands)20242023
Balance at beginning of period$18,810 $21,109 
Net change in valuation allowance(3,148)(2,299)
Balance at end of period$15,662 $18,810 
Schedule of Unrecognized Tax Benefits RollForward
The following table reflects changes to and balances of the Company's unrecognized tax benefits:

(in thousands)202420232022
Balance at beginning of period $17,140 $21,443 $20,834 
Gross additions for tax positions related to the current year774 624 423 
Gross additions for tax positions related to prior years150 201 332 
Gross reductions for tax positions related to prior years— (5,128)— 
Gross reductions for tax positions related to the lapse of applicable statute of limitations— — (146)
Balance at end of period$18,064 $17,140 $21,443